LAG3 and breast cancer: Previously, we showed that the co-blockade of PD-1 and PD-L1 upregulated the surface expression of CTLA-4, TIM-3, and LAG-3 on CD4+ T cell subsets by using a co-culture system with human breast cancer cell lines [20].